Patients who meet the following criteria may be eligible to participate: Inclusion • Male or female subjects, ≥50 years of age. • Documented diagnosis of wAMD in the study eye, with onset of disease that began at any time prior to the Screening Visit. • Active subfoveal CNV due to wAMD, including juxtafoveal lesions that affect the fovea, as defined by presence of fluid (intraretinal or subretinal) affecting the central subfield as measured by SD-OCT. Exclusion • CNV caused by ocular histoplasmosis, pathological myopia, angioid streaks, choroidal rupture, uveitis, and trauma. • Fibrosis >50% of the total lesion. This is not a full list of criteria.